Scotiabank Has Bullish Outlook for Albemarle FY2026 Earnings

Albemarle Corporation (NYSE:ALB) – Equities researchers at Scotiabank boosted their FY2026 earnings per share (EPS) estimates for shares of Albemarle in a note issued to investors on Monday, November 10th. Scotiabank analyst B. Isaacson now expects that the specialty chemicals company will earn $1.92 per share for the year, up from their prior estimate of $1.24. Scotiabank currently has a “Sector Perform” rating and a $85.00 target price on the stock. The consensus estimate for Albemarle’s current full-year earnings is ($0.04) per share.

Albemarle (NYSE:ALB) last released its quarterly earnings data on Wednesday, November 5th. The specialty chemicals company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.92) by $0.73. The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.27 billion. Albemarle had a negative return on equity of 1.87% and a negative net margin of 18.61%.The business’s revenue for the quarter was down 3.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($1.55) EPS.

Other equities research analysts have also issued research reports about the stock. Cowen restated a “hold” rating on shares of Albemarle in a research note on Thursday, October 9th. Bank of America reissued a “neutral” rating and issued a $100.00 price objective (up from $95.00) on shares of Albemarle in a report on Tuesday, October 14th. Wells Fargo & Company lifted their target price on Albemarle from $90.00 to $100.00 and gave the company an “equal weight” rating in a research note on Tuesday. Rothschild & Co Redburn assumed coverage on Albemarle in a research report on Friday, October 24th. They set a “buy” rating and a $135.00 price target for the company. Finally, Jefferies Financial Group raised their price target on Albemarle from $105.00 to $124.00 in a report on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, sixteen have assigned a Hold rating and five have issued a Sell rating to the company’s stock. According to data from MarketBeat, Albemarle has a consensus rating of “Hold” and a consensus target price of $99.38.

Albemarle Stock Up 3.9%

ALB stock opened at $114.59 on Thursday. The company has a quick ratio of 1.47, a current ratio of 2.31 and a debt-to-equity ratio of 0.38. The firm’s 50-day simple moving average is $90.28 and its 200 day simple moving average is $75.64. The stock has a market cap of $13.49 billion, a PE ratio of -12.30 and a beta of 1.70. Albemarle has a fifty-two week low of $49.43 and a fifty-two week high of $119.28.

Albemarle Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 2nd. Stockholders of record on Friday, December 12th will be paid a $0.405 dividend. This represents a $1.62 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, December 12th. Albemarle’s payout ratio is currently -101.89%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of ALB. Manning & Napier Advisors LLC bought a new stake in Albemarle during the third quarter worth approximately $138,723,000. ProShare Advisors LLC lifted its position in shares of Albemarle by 48.5% during the 2nd quarter. ProShare Advisors LLC now owns 2,870,110 shares of the specialty chemicals company’s stock valued at $179,870,000 after acquiring an additional 937,538 shares during the last quarter. AQR Capital Management LLC boosted its stake in shares of Albemarle by 22,047.4% during the 2nd quarter. AQR Capital Management LLC now owns 713,812 shares of the specialty chemicals company’s stock worth $44,613,000 after acquiring an additional 710,589 shares in the last quarter. FengHe Fund Management Pte. Ltd. acquired a new position in shares of Albemarle in the 2nd quarter worth $32,903,000. Finally, PGGM Investments raised its position in shares of Albemarle by 90.4% during the second quarter. PGGM Investments now owns 1,069,924 shares of the specialty chemicals company’s stock worth $67,052,000 after purchasing an additional 507,975 shares during the period. Institutional investors own 92.87% of the company’s stock.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.